Filing in this field is concentrated: the top five assignees together hold 61.4% of the 1,907 records in scope, with the single leading company holding 509 records on its own. Beyond the top ranks, filing thins out quickly into a long tail of companies with only a handful of records each. This pattern means the practical competitive picture is set mostly by a small number of established cardiac device makers rather than by a broad field of active filers.

Annual filings peaked in 2022 at 59 and then fell to 10 by 2024, a 79% drop over that three-year span, which is the last period with complete publication data. This looks like a genuine pullback in new telemetry-specific filings rather than a sign the field is inactive, since the underlying devices continue to ship. Figures for 2025 and 2026 are still incomplete because publication typically lags filing by around 18 months, so the most recent years should not yet be read as confirming or reversing the trend.

Almost all records, 96.6%, carry the A61N electrotherapy classification, confirming that telemetry claims are overwhelmingly filed as features of the implantable device rather than as standalone communications inventions. A61B (diagnosis and surgery) appears on 32.1% of records, reflecting monitoring and diagnostic overlap. Dedicated communications classifications are comparatively rare — H04B at 4.8% and H04W at 4.4% — which suggests the radio-protocol layer of these systems is still a smaller, less-crowded slice of the claim space than the device layer it serves.

The technology composition data suggests the communications-specific classes are the thinner layer: H04B and H04W each sit under 5% of the 1,907 records, well below A61N's 96.6% and A61B's 32.1%. That gap indicates most existing claims treat wireless communication as incidental to the implant rather than as the core inventive step, leaving room for claims that focus specifically on protocol, power-efficient transceiver design, or multi-device coordination. Co-filing is also unusually rare in this field, with only 10 co-assignee pairs recorded, so partnership-based filing strategies are largely untested here.

US7565195B1, assigned to Pacesetter, Inc. and published in 2009, describes a failsafe satellite pacemaker system in which multiple satellite pacemakers monitor each other's pacing pulses and a surrogate takes over if a pulse is missed, coordinated wirelessly with a master pacemaker. It matters as a reference point for any multi-device or redundant pacing architecture that relies on wireless coordination between implants. Because it is an older, foundational-style filing, it is useful for understanding claim scope and prior art boundaries rather than as a signal of current commercial activity.